Products for Research Use Only
RegisterLogin

Geptanolimab

CAT: 0804-HY-P99639-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99639-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Geptanolimab (CBT-501) is a humanized IgG4k monoclonal antibody against programmed death-1 (PD-1) . Siplizumab inhibits the binding of PD-L1/L2 to PD-1 through a competitive action. Siplizumab can be used in research of cancer[1].
CAS Number
2348469-43-0
Product Name Alternative
Genolimzumab; APL-501; CBT-501; GB-226
UNSPSC
12352203
Target
PD-1/PD-L1
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/geptanolimab.html
Purity
97.72
Solubility
10 mM in DMSO
Smiles
[Geptanolimab]
Molecular Weight
(144.14 kDa)
References & Citations
[1]Qing Z, et, al. Activity of CBT-501, a novel humanized anti-PD-1 antibody, in a humanized genetically engineered mouse model of colon carcinoma. Journal of Clinical Oncology. 2017;35 (7_suppl) :108-108.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2

Alternative Products

CatalogName
abx831638-01Geptanolimab
GTR18337744-01Geptanolimab Antibody
HS870246-01Research Grade Geptanolimab
E55B0775Geptanolimab (Reference antibody)
ICH5243-5mgGeptanolimab Biosimilar - Research Grade
A138047Geptanolimab Biosimilar (Monoclonal, IgG4)
GTR18697392-01Geptanolimab Human Monoclonal Antibody
21-916Geptanolimab - Research Grade Biosimilar
GTR18780557-01(Geptanolimab) Biosimilar Reference Antibody
RA0564-01Geptanolimab (Biosimilar Reference Antibody) (PDCD1)

Popular Products